Blog Post Explores Global Fund’s Efforts To Address HIV Drug Resistance Worldwide

Friends of the Global Fight: Vigilance in Tackling Drug Resistance in the Global Battle Against HIV
In this blog post, the third in a series of posts exploring the threat that drug resistance poses to HIV/AIDS, TB, and malaria efforts, Mark P. Lagon, chief policy officer, and John McMannis, communications manager, both at Friends of the Global Fight, discuss how “an increase in [antiretroviral (ARV)] drug resistance is posing a significant threat to progress to date, and to our ability to end the [HIV/AIDS] epidemic.” The authors conclude, “[W]ith strategic investment, the Global Fund can build on its existing strategy of working hand-in-hand on Country Operational Plans and implementation with the U.S. President’s Emergency Plan for AIDS Relief, and place countries on the best possible footing to fight drug resistance in HIV” (1/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.